Watch Ticker

Akero Therapeutics, Inc. Common Stock

Go to Akero Therapeutics, Inc. Common Stock Website

$20.14

(%)

Live

Previous Close

$20.14

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$1.4 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a d...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Perrigo (PRGO) to Report Q1 Earnings: Here's What to Expect

Perrigo's (PRGO) new products and products added through acquisitions are expected to have aided the top line in the soon-to-be-reported quarter.

Related tickers: PRGO, SRPT, ARGX, AKRO.

Read Full Article

Zacks Equity Research - Madrigal (MDGL) Stock Up as FDA Approves First Drug for NASH

Madrigal Pharmaceuticals' (MDGL) Rezdiffra (resmetirom) is the first and only medicine approved by the FDA for the treatment of NASH.

Related tickers: LLY, VKTX, MDGL, AKRO.

Read Full Article

Trending Tickers

FLGC

XNAS

$1.23

(%)

IBIT

XNAS

$39.97

(%)

LASE

XNAS

$2.28

(%)

MGAM

XNAS

$0.02

(%)

MLGO

XNAS

$0.00

(%)